“Enhancing the Bioavailability of Quercetin by Concomitant Administration with Enzyme Inhibitor”, Journal of Pharmaceutical Negative Results, pp. 981–991, Oct. 2022, doi: 10.47750/pnr.2022.13.S06.131.